Martinez-Piñeiro J A, Muntanola P, Hidalgo L
Eur Urol. 1977;3(3):159-62. doi: 10.1159/000472083.
The immunological competence of 100 patients bearing urological cancers was evaluated by means of skin tests and serum immunoelectrophoresis. Cell-mediated immunodepressions were observed in 93.3% of prostatic cancers, 68.6% of bladder cancers and 38.4% of renal cancers. The immunoglobulin values increased in 80% of prostatic cancers, 31.3% of bladder cancers and in 23% of renal cancers. IgA was elevated in almost all the prostatic growths. In bladder and renal cancers a clear correlation between immunodepression and tumour stage was found. Treatment significantly improved the skin test reactivity in the evaluated patients. Metastases and recurrences occurred more frequently in immunodepressed subjects.
通过皮肤试验和血清免疫电泳对100例患有泌尿系统癌症的患者的免疫能力进行了评估。在93.3%的前列腺癌、68.6%的膀胱癌和38.4%的肾癌患者中观察到细胞介导的免疫抑制。80%的前列腺癌、31.3%的膀胱癌和23%的肾癌患者免疫球蛋白值升高。几乎所有前列腺肿瘤中IgA均升高。在膀胱癌和肾癌中,发现免疫抑制与肿瘤分期之间存在明显相关性。治疗显著改善了所评估患者的皮肤试验反应性。免疫抑制患者发生转移和复发的频率更高。